These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31752117)

  • 1. miRNA-29b Inhibits Prostate Tumor Growth and Induces Apoptosis by Increasing Bim Expression.
    Sur S; Steele R; Shi X; Ray RB
    Cells; 2019 Nov; 8(11):. PubMed ID: 31752117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling.
    Ru P; Steele R; Newhall P; Phillips NJ; Toth K; Ray RB
    Mol Cancer Ther; 2012 May; 11(5):1166-73. PubMed ID: 22402125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-Coding RNA AC008972.1 as a Novel Therapeutic Target for Prostate Cancer.
    Zeng Q; Liu J; Wu Q; Song R; Miao W; Ma Y; Yang H
    Cancer Biother Radiopharm; 2024 May; 39(4):291-305. PubMed ID: 36094409
    [No Abstract]   [Full Text] [Related]  

  • 4. miR-105 inhibits prostate tumour growth by suppressing CDK6 levels.
    Honeywell DR; Cabrita MA; Zhao H; Dimitroulakos J; Addison CL
    PLoS One; 2013; 8(8):e70515. PubMed ID: 23950948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
    Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
    Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovering the Biological Significance and Therapeutic Potential of miR-29b-3p in Triple-Negative Breast Cancer.
    Jurj A; Zanoaga O; Raduly L; Morhan V; Papi Z; Ciocan C; Pop LA; Berindan-Neagoe I; Braicu C
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of miRNA-15a and miRNA-16-1 using cationic PEGylated niosomes downregulates Bcl-2 and induces apoptosis in prostate cancer cells.
    Ghaffari M; Kalantar SM; Hemati M; Dehghani Firoozabadi A; Asri A; Shams A; Jafari Ghalekohneh S; Haghiralsadat F
    Biotechnol Lett; 2021 May; 43(5):981-994. PubMed ID: 33515341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer.
    Wu D; Chen B; Cui F; He X; Wang W; Wang M
    Cell Prolif; 2016 Aug; 49(4):476-83. PubMed ID: 27352910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro.
    Tan G; Jiang L; Li G; Bai K
    Technol Cancer Res Treat; 2020; 19():1533033820948062. PubMed ID: 33063634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2.
    Li Q; Lu S; Li X; Hou G; Yan L; Zhang W; Qiao B
    Clin Transl Oncol; 2017 May; 19(5):562-570. PubMed ID: 27921232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of protein kinase CK2 downregulation and inhibition on oncomir clusters 17 ~ 92 and 106b ~ 25 in prostate, breast, and head and neck cancers.
    Kren BT; Henzler CM; Ahmed K; Trembley JH
    Mol Med; 2024 Oct; 30(1):175. PubMed ID: 39394061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p.
    Barbier RH; McCrea EM; Lee KY; Strope JD; Risdon EN; Price DK; Chau CH; Figg WD
    Sci Rep; 2021 May; 11(1):10765. PubMed ID: 34031488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial effects of miR-20a and miR-29b on neuronal apoptosis induced by spinal cord injury.
    Liu XJ; Zheng XP; Zhang R; Guo YL; Wang JH
    Int J Clin Exp Pathol; 2015; 8(4):3811-8. PubMed ID: 26097563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
    Li C; Wang P; Du J; Chen J; Liu W; Ye K
    IUBMB Life; 2021 Jan; 73(1):286-298. PubMed ID: 33314669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ).
    Liu HJ; Lam HC; Baglini CV; Nijmeh J; Cottrill AA; Chan SY; Henske EP
    Oncogene; 2019 Dec; 38(49):7367-7383. PubMed ID: 31420607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
    Amir S; Ma AH; Shi XB; Xue L; Kung HJ; Devere White RW
    PLoS One; 2013; 8(4):e61064. PubMed ID: 23585871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.